Conversely, miR-3614-5p was proposed to attenuate proliferation and invasion of non-small cell lung cancer cells by targeting the glycolysis enzyme phosphoglycerate mutase 1 (PGAM1) (7) and the WNT pathway-related NFATC2 transcription factor (8). The gene discussed is PGAM1; the disease is non-small cell lung carcinoma.